Effects of M-DEPTH Model of Depression Care on Maternal HIV Viral Suppression and Adherence to the PMTCT Care Continuum Among HIV-Infected Pregnant Women in Uganda: Results from a Cluster Randomized Controlled Trial at Pregnancy Completion

Glenn Wagner1, Violet Gwokyalya2, Laura J. Faherty1, Dickens Akena3, Janet Nakigudde3, Victoria K. Ngo4, Ryan McBain1, Bonnie Ghosh-Dastidar1, Jolly Beyeza-Kashesya5, Juliet Nakku6, Leticia Kyohangirwe6, Linda Nabitaka7, Hafsa Lukwata7, Barbara Mukasa8, Rhoda K. Wanyenze2
1RAND Corporation,1776 Main Street, Santa Monica, CA, 90407, USA
2Makerere University School of Public Health, Kampala, Uganda
3College of Health Sciences, Makerere University, Kampala, Uganda
4RAND Corporation, 1776 Main Street, Santa Monica, CA 90407, USA
5Mulago Specialized Women and Neonatal Hospital, Kampala, Uganda
6Butabika National Referral Mental Hospital, Kampala, Uganda
7Ministry of Health, Kampala, Uganda
8Mildmay Uganda, Kampala, Uganda

Tóm tắt

AbstractPerinatal depression has been shown to impede adherence to antiretroviral therapy (ART) and the prevention of mother-to-child transmission (PMTCT) care continuum; therefore, treating perinatal depression may result in increased viral suppression and PMTCT adherence. We examined the effects of the M-DEPTH (Maternal Depression Treatment in HIV) depression care model (including antidepressants and individual Problem Solving Therapy) on depression, maternal viral suppression and adherence to PMTCT care processes in an ongoing cluster-randomized controlled trial of 391 HIV-infected pregnant women (200 usual care; 191 intervention) with at least mild depressive symptoms enrolled across 8 antenatal care clinics in Uganda. At baseline, 68.3% had clinical depression and 41.7% had detectable HIV viral load. Adjusted repeated-measures multivariable regression models found that the intervention group was nearly 80% less likely to be clinically depressed [Adjusted OR (95% CI) 0.22 (0.05, 0.89)] at the 2-month post-pregnancy assessment, compared to the control group. However, the intervention and control groups did not differ meaningfully on maternal viral suppression, ART adherence, and other PMTCT care processes and outcomes. In this sample of women who were mostly virally suppressed and ART adherent at baseline, the depression care model had a strong effect on depression alleviation, but no downstream effects on viral suppression or other PMTCT care processes.Trial Registration NIH Clinical Trial Registry NCT03892915 (clinicaltrials.gov).

Từ khóa


Tài liệu tham khảo

Audureau E, Kahn JG, Besson M-H, Saba J, Ladner J. Scaling up prevention of mother-to-child HIV transmission programs in sub-Saharan African countries: a multilevel assessment of site-, program- and country-level determinants of performance. BMC Public Health. 2013;13(1):286.

Commission UA. Uganda HIV/AIDS Country Progress Report July 2016–June 2017; 2018.

Muyindike W, Fatch R, Steinfield R, et al. Contraceptive use and associated factors among women enrolling into HIV care in southwestern Uganda. Infect Dis Obstet Gynecol. 2012;2012: 340782.

UNAIDS. Uganda Country Report. Kampala, Uganda: Uganda Ministry of Health; 2014.

Rochat TJ, Bland RM, Tomlinson M, Stein A. Suicide ideation, depression and HIV among pregnant women in rural South Africa. 2013.

Kwalombota M. The effect of pregnancy in HIV-infected women. AIDS Care. 2002;14(3):431–3.

Rochat TJ, Tomlinson M, Newell M-L, Stein A. Detection of antenatal depression in rural HIV-affected populations with short and ultrashort versions of the Edinburgh Postnatal Depression Scale (EPDS). Arch Womens Ment Health. 2013;16(5):401–10.

Antelman G, Kaaya S, Wei R, et al. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr (1999). 2007;44(4):470.

Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during and after pregnancy in low-, middle and high income countries: a systematic review and meta-analysis. AIDS (London, England). 2012;26(16):2039.

Kapetanovic S, Christensen S, Karim R, et al. Correlates of perinatal depression in HIV-infected women. AIDS Patient Care STDS. 2009;23(2):101–8.

Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67(10):1012–24.

Surkan PJ, Kennedy CE, Hurley KM, Black MM. Maternal depression and early childhood growth in developing countries: systematic review and meta-analysis. Bull World Health Organ. 2011;89(8):607–15.

Sam-Agudu NA, Cornelius LJ, Okundaye JN, et al. The impact of mentor mother programs on PMTCT service uptake and retention-in-care at primary health care facilities in Nigeria: a prospective cohort study (MoMent Nigeria). JAIDS J Acquir Immune Defic Syndr. 2014;67:S132–8.

Safren SA, O’cleirigh C, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28(1):1.

Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. JAIDS J Acquir Immune Defic Syndr. 2005;38(4):432–8.

Sin NL, DiMatteo MR. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med. 2014;47(3):259–69.

Kigozi F, Ssebunnya J, Kizza D, Cooper S, Ndyanabangi S. An overview of Uganda’s mental health care system: results from an assessment using the world health organization’s assessment instrument for mental health systems (WHO-AIMS). Int J Ment Health Syst. 2010;4(1):1–9.

Patel V, Araya R, Chatterjee S, et al. Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet. 2007;370(9591):991–1005.

Patel V, Weiss HA, Chowdhary N, et al. Effectiveness of an intervention led by lay health counsellors for depressive and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomised controlled trial. Lancet. 2010;376(9758):2086–95.

Simon G. Collaborative care for mood disorders. Curr Opin Psychiatry. 2009;22(1):37–41.

Wagner GJ, Ghosh-Dastidar B, Robinson E, et al. Effects of depression alleviation on ART adherence and HIV clinic attendance in Uganda, and the mediating roles of self-efficacy and motivation. AIDS Behav. 2017;21(6):1655–64.

Nyamayaro P, Bere T, Magidson JF, et al. A task-shifting problem-solving therapy intervention for depression and barriers to antiretroviral therapy adherence for people living with HIV in Zimbabwe: case series. Cogn Behav Pract. 2020;27(1):84–92.

Udedi M, Stockton MA, Kulisewa K, et al. Integrating depression management into HIV primary care in central Malawi: the implementation of a pilot capacity building program. BMC Health Serv Res. 2018;18(1):1–12.

Grote NK, Katon WJ, Lohr MJ, et al. Culturally relevant treatment services for perinatal depression in socio-economically disadvantaged women: the design of the MOMCare study. Contemp Clin Trials. 2014;39(1):34–49.

LaRocco-Cockburn A, Reed SD, Melville J, et al. Improving depression treatment for women: integrating a collaborative care depression intervention into OB-GYN care. Contemp Clin Trials. 2013;36(2):362–70.

Wagner GJ, McBain RK, Akena D, et al. Maternal depression treatment in HIV (M-DEPTH): study protocol for a cluster randomized controlled trial. Medicine. 2019;98(27):e16329.

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.

Nakku J, Rathod S, Kizza D, et al. Validity and diagnostic accuracy of the Luganda version of the 9-item and 2-item Patient Health Questionnaire for detecting major depressive disorder in rural Uganda. Global Mental Health. 2016. https://doi.org/10.1017/gmh.2016.14.

Klar N, Gyorkos T, Donner A. Cluster randomization trials in tropical medicine: a case study. Trans R Soc Trop Med. 1995;89(4):454–9.

World Health Organization. WHO multi-country study on women’s health and domestic violence against women: initial results on prevalence, health outcomes and women’s responses. Geneva: World Health Organization; 2005.

Health UMo. The role of Family Support Groups towards elimination of mother to child transmission of HIV in Uganda: an assessment report; 2017.

WHO. WHO Guidelines Approved by the Guidelines Review Committee. mhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings: Mental Health Gap Action Programme (mhGAP): Version 2.0. Geneva: World Health Organization. Copyright © World Health Organization 2016; 2016.

Malouff JM, Thorsteinsson EB, Schutte NS. The efficacy of problem solving therapy in reducing mental and physical health problems: a meta-analysis. Clin Psychol Rev. 2007;27(1):46–57.

Cuijpers P, van Straten A, Warmerdam L. Problem solving therapies for depression: a meta-analysis. Eur Psychiatry. 2007;22(1):9–15.

Bell AC, D’Zurilla TJ. Problem-solving therapy for depression: a meta-analysis. Clin psychol rev. 2009;29(4):348–53.

Hackley B. Antidepressant medication use in pregnancy. J Midwifery Womens Health. 2010;55(2):90–100.

Yonkers KA, Blackwell KA, Forray A. Antidepressant use in pregnant and postpartum women. Annu Rev Clin Psychol. 2014;10:369.

O’Connor E, Rossom RC, Henninger M, Groom HC, Burda BU. Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016;315(4):388–406.

Kaymaz N, van Os J, Loonen AJ, Nolen WA. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry. 2008;69(9):6813.

Association D-AP. Diagnostic and statistical manual of mental disorders. Arlington: American Psychiatric Publishing; 2013.

Monahan PO, Shacham E, Reece M, et al. Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya. J Gen Intern Med. 2009;24(2):189–97.

Tuthill EL, Pellowski JA, Young SL, Butler LM. Perinatal depression among HIV-infected women in KwaZulu-Natal South Africa: prenatal depression predicts lower rates of exclusive breastfeeding. AIDS Behav. 2017;21(6):1691–8.

Wang L, Kroenke K, Stump TE, Monahan PO. Screening for perinatal depression with the patient health questionnaire depression scale (PHQ-9): a systematic review and meta-analysis. Gen Hosp Psychiatry. 2021;68:74–82.

Faherty L, Gwokyalya V, Akena D, McBain R, Ngo V, Nakigudde J, Nakku J, Mukasa B, Beyeza-Kashesya J, Wanyenze R, Wagner G. Outcomes of depression treatment among pregnant women with HIV in Uganda.

Sabin LL, Halim N, Hamer DH, et al. Retention in HIV care among HIV-seropositive pregnant and postpartum women in Uganda: results of a randomized controlled trial. AIDS Behav. 2020;24(11):3164–75.

Grossberg R, Gross R. Use of pharmacy refill data as a measure of antiretroviral adherence. Curr HIV/AIDS Rep. 2007;4(4):187–91.